淋巴结针对免疫治疗的向
Y Wang1,2, H Wang1,3,4,5,6,7,8
1Department of Materials Science and Engineering, University of Illinois at Urbana-Champaign, Urbana, USA.
Immuno-oncology technology
|September 18, 2023
概括
本综述探讨了用于增强免疫治疗的先进淋巴结向技术. 这些策略旨在改善免疫细胞的反应,以更好地治疗癌症等疾病.
科学领域:
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
- 药物运输 药物运输 药物运输
背景情况:
- 免疫疗法已经取得了显著的进步,通过检查点阻塞,CAR T细胞疗法和疫苗在癌症治疗方面取得了成功.
- 有效的免疫疗法依赖于强大,持久的免疫反应,由抗原呈现细胞驱动,在淋巴结中启动T和B细胞.
- 直接向淋巴结输送免疫调节剂对于强烈的免疫反应至关重要.
研究的目的:
- 为免疫治疗提供淋巴结向技术的全面概述.
- 讨论各种被动和主动准策略的机制和优势.
- 突出促进免疫调节剂向淋巴结内的免疫细胞递送的进展.
主要方法:
- 审查关于淋巴结向技术的现有文献.
- 对将免疫调节剂输送到淋巴结的策略进行分析.
- 讨论内节注射限制和替代向方法.
主要成果:
- 已经开发出多种被动和主动技术来克服内节注射的挑战.
- 这些技术旨在改善免疫调节剂的传递到淋巴结中的抗原呈现细胞和淋巴细胞.
- 这篇评论详细介绍了各种淋巴结向方法的机制和优点.
结论:
- 淋巴结向技术对于优化免疫疗法疗效至关重要.
- 向策略的进步提高了对抗原特异性T细胞和B细胞的原始化.
- 该领域的进一步发展有望改善各种疾病的治疗结果.
相关概念视频
Tumor Immunotherapy
554
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
554
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


